meddevicedb.com FDA Device Reference

ELITECH CLINICAL SYSTEMS CREATININE PAP SL, ELICAL 2, ELITROL I AND ELITROL II, URINE CONTROL BI-LEVEL

K132399 Class II Traditional
Decision Date
2014-01-03
Sponsor / Applicant
Elitechgroup

Technical Specification

510(k) Submission ID K132399
Product Code JFY
Medical Specialty / Panel Clinical Chemistry
Regulation Citation 21 CFR 862.1225
Decision Date 2014-01-03
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

ELITECH CLINICAL SYSTEMS CREATININE PAP SL, ELICAL 2, ELITROL I AND ELITROL II, URINE CONTROL BI-LEVEL received FDA 510(k) clearance under submission number K132399, sponsored by Elitechgroup. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2014-01-03.

Classification & Regulation

This clearance is catalogued under FDA product code JFY and 21 CFR 862.1225, within the Clinical Chemistry review panel as a Class II device.